Lisata Therapeutics (LSTA) stock lost in reaction to data from a mid-stage trial for its main asset, certepetide, in patients with pancreatic cancer. Read more here.
Casdozokitug, in combination with atezolizumab/bevacizumab, final data demonstrate durability of response and improvement in depth of response including a 17.2% complete response rate – – Antitumor ...
For Kelly Heather, 38, from Gravesend, it was a positive moment, after what had been a difficult few years. But then, on December 2, she had a seizure and was later diagnosed with a brain tumour.
A clinical trial demonstrates the effectiveness of telephone-delivered acceptance and commitment therapy (ACT) in reducing fatigue's interference with functioning and improving the quality of life for ...
The American Cancer Society's annual trend report is out with some mixed results. Cancer deaths are down but cases among certain groups are up. Jamil Rivers, a South Jersey mother of two, was ...
A breast cancer survivor received an unexpected gift this week from Tina's Angels, a national organization dedicated to creating lasting memories for families a ...